|
KR20040046874A
|
|
A Pharmaceutical Composition For Treatment And Prevention of Solid Cancer Comprising Naphthazarin Derivative S64
|
|
KR20040025184A
|
|
Method And DNA Chip For Monitoring Response of Irradiation on Cancer Patients Using Hsp Gene Expression Analysis
|
|
KR20040025185A
|
|
Method And DNA Chip For Monitoring Response of Irradiation on Cancer Patients Using Cytokine Gene Expression Analysis
|
|
KR20040025183A
|
|
Method And DNA Chip For Monitoring Response of Irradiation on Cancer Patients Using Antioxidant Gene Expression Analysis
|
|
KR20030092462A
|
|
Method and kit for diagnosis of progress stage of cancer
|
|
KR20030092378A
|
|
Method and kit for diagnosis of progress stage of solid cancer
|
|
KR20030080601A
|
|
An Assay of Modified Glycoproteins And A Method for Evaluating Effect of Irradiation on Animial Body
|
|
KR20030079098A
|
|
An Assay of Thiol Modified Proteins
|
|
KR20030033519A
|
|
Method for determining radiation sensitivity of animal by activities of antioxidative enzyme
|
|
KR20030033526A
|
|
Method for determining radiation sensitivity of animal by activities of antioxidative enzymes in fluid
|
|
KR20030033518A
|
|
Method for determining radiation sensitivity of animal by activities of glutathione related enzymes
|
|
KR20030008319A
|
|
A Lung Protecting Agent Comprising 1,10-phenanthroline as Active Ingredient
|
|
KR20030015815A
|
|
Method For Inhibiting VEGF And EPO Gene Expression By Quercetin
|
